Orgoi Sergelen

Sergelen earned a Bachelor of Medicine (BM) in 1982, a Master of Clinical Medicine (MM) in 1983, a Doctor of Medicine (MD) in 1997, and a Doctor of Philosophy (PhD) in 2002 from the Mongolian National University of Medical Sciences (MNUMS).[5] She completed medical fellowships in developed countries such as South Korea, Switzerland, USA, and Finland.[5]

Sergelen taught surgery at the Mongolian National University of Medical Sciences from 1982 to 2002. In 2002, she became the Head of the Surgery Department there, and she holds this position to present date.[5]

In 2011, Sergelen and her team of surgeons did the first successful liver transplantation in Mongolia at the First Central Hospital of Mongolia.[6] Her team had done test surgeries on 26 pigs for three years.[7] Since then, her team has done 47 liver transplantations in Mongolia.[6] Recognizing that liver cancer is the most prevalent and economically disastrous cancer in Mongolia, Sergelen led the development of low-cost liver transplants in Mongolia.[1] Now liver transplants cost MNT 10-15 million (around US$3–5 thousand).[6] She proposed that Mongolian state health budget cover all liver transplantations. Now the state budget covers 75 percent of all liver transplantations in Mongolia.[6]

In 2017, Sergelen was honored by the American College of Surgeons with the Honorary Fellowship award for her commitment to treating the people of her country Mongolia.[3] The American College of Surgeons praised that

“Professor Sergelen has been a true pioneer in modern surgical care. She challenged the popular dogma that surgery was too expensive and instead showed to the world that surgery can reach all communities. Problems of a rugged geography, serious political and financial constraints, and the large nomadic setting have never prevented her from improving health care in Mongolia. Despite her naysayers, she led projects that are presenting impressive examples of possibilities for other low and middle income countries. Professor Sergelen is one of modern surgery’s most impactful leaders for low and middle income countries.”[3]